A mixed therapy minimal model: Some strategies for eradication or minimization of cancer

BACKGROUND AND OBJECTIVE In most of the cancer therapeutic models separate equations for consumption of drugs are used, we however use parameters m and s to see the effect of chemotherapy and immunotherapy respectively. The main objective of this theoretical study is to develop strategies for eradication or minimization of cancer. METHODS Linearization method to study the local stability of model equilibria. RESULTS The results obtained in this study provide thresholds on m-fraction of cancer cells killed by chemotherapy and s-fraction of immune cells stimulated by immunotherapy. CONCLUSION The model considered relates to immune-cancer-normal cell interactions in post vascularization process. The study aims to develop strategies for complete eradication or minimization of cancer in terms of model parameters. This paper presents a minimal immuno-chemotherapeutic cancer model by describing interacting dynamics of cancer, immune and normal cells in a system of three ordinary differential equations. The source of the immune cells is considered outside the sytem given by a constant influx rate, s. The minimality of the model lies in not considering a separate equation for the dynamics of the drug but its overall killing effect on the cancer cells represented by a parameter, m. Thus the parameter m relates to chemotherapy and s to immunotherapy. The analysis of the model yields thresholds on these parameters for therapeutic strategies which guarantee either eradication or minimization of cancer from a patient's body.

[1]  Giuseppe Jordão,et al.  Mathematical models in cancer therapy , 2017, Biosyst..

[2]  Riaan Conradie,et al.  Restriction point control of the mammalian cell cycle via the cyclin E/Cdk2:p27 complex , 2010, The FEBS journal.

[3]  Zhibin Jiang,et al.  Optimization of combination chemotherapy with dose adjustment using a memetic algorithm , 2018, Inf. Sci..

[4]  J. Usher,et al.  Some mathematical models for cancer chemotherapy , 1994 .

[5]  A. Cerone,et al.  Mathematical modeling of drug resistance due to KRAS mutation in colorectal cancer. , 2016, Journal of theoretical biology.

[6]  D. Kirschner,et al.  Modeling immunotherapy of the tumor – immune interaction , 1998, Journal of mathematical biology.

[7]  Ami Radunskaya,et al.  A delay differential equation model for tumor growth , 2003, Journal of mathematical biology.

[8]  J. Panetta,et al.  A mathematical model of periodically pulsed chemotherapy: tumor recurrence and metastasis in a competitive environment. , 1996, Bulletin of mathematical biology.

[9]  A. Radunskaya,et al.  Mathematical Model of Colorectal Cancer with Monoclonal Antibody Treatments , 2013, 1312.3023.

[10]  Gabriela Ochoa,et al.  Heuristic design of cancer chemotherapies , 2004, IEEE Transactions on Evolutionary Computation.

[11]  J. Hale Theory of Functional Differential Equations , 1977 .

[12]  Benedetto Piccoli,et al.  Optimal Control in a Model of Dendritic Cell Transfection Cancer Immunotherapy , 2006 .

[13]  H. I. Freedman,et al.  A mathematical model of vascular tumor treatment by chemotherapy , 2005, Math. Comput. Model..

[14]  H. Namazi,et al.  Mathematical Modelling and Prediction of the Effect of Chemotherapy on Cancer Cells , 2015, Scientific Reports.

[15]  M. Okada-Hatakeyama,et al.  Current status of mathematical modeling of cancer – From the viewpoint of cancer hallmarks , 2017 .

[16]  Ricardo Gómez Aiza,et al.  Analysis of a mathematical model of periodically pulsed chemotherapy treatment , 2017 .

[17]  Alexander Lorz,et al.  Asymptotic analysis and optimal control of an integro-differential system modelling healthy and cancer cells exposed to chemotherapy , 2016, Journal de Mathématiques Pures et Appliquées.

[18]  M. Kolev Mathematical modelling of the competition between tumors and immune system considering the role of the antibodies , 2003 .

[19]  Lin Shen,et al.  Mathematical Modelling and Analysis of the Tumor Treatment Regimens with Pulsed Immunotherapy and Chemotherapy , 2016, Comput. Math. Methods Medicine.

[20]  G. P. Samanta,et al.  Dynamical Behaviour of a Tumor-Immune System with Chemotherapy and Optimal Control , 2013 .

[21]  Mustafa Mamat,et al.  Mathematical Model of Cancer Treatments Using Immunotherapy, Chemotherapy and Biochemotherapy , 2013 .

[22]  Martin M. Eisen,et al.  Mathematical Models in Cell Biology and Cancer Chemotherapy , 1979 .

[23]  Refael Hassin,et al.  Optimizing Chemotherapy Scheduling Using Local Search Heuristics , 2006, Oper. Res..

[24]  Urszula Ledzewicz,et al.  Optimal Control for Mathematical Models of Cancer Therapies: An Application of Geometric Methods , 2015 .

[25]  A. Ghaffari,et al.  Mathematical Modeling and Lyapunov-Based Drug Administration in Cancer Chemotherapy , 2009 .

[26]  G. D. Knott,et al.  Modeling tumor regrowth and immunotherapy , 2001 .

[27]  Olivier Fercoq,et al.  Optimisation of Cancer Drug Treatments Using Cell Population Dynamics , 2013 .

[28]  George W. Swan,et al.  Applications of Optimal Control Theory in Biomedicine , 1984 .

[29]  John J Tyson,et al.  A model for restriction point control of the mammalian cell cycle. , 2004, Journal of theoretical biology.

[30]  T. Wheldon Mathematical models in cancer research , 1988 .

[31]  A. Jemal,et al.  Global cancer transitions according to the Human Development Index (2008-2030): a population-based study. , 2012, The Lancet. Oncology.

[32]  Ami Radunskaya,et al.  A mathematical tumor model with immune resistance and drug therapy: an optimal control approach , 2001 .

[33]  R. Gatenby,et al.  Models of tumor-host interaction as competing populations: implications for tumor biology and treatment. , 1995, Journal of theoretical biology.

[34]  H. I. Freedman,et al.  A mathematical model of cancer treatment by immunotherapy. , 2000, Mathematical biosciences.

[35]  Efstratios N. Pistikopoulos,et al.  Optimal delivery of chemotherapeutic agents in cancer , 2008, Comput. Chem. Eng..

[36]  Ami Radunskaya,et al.  The dynamics of an optimally controlled tumor model: A case study , 2003 .

[37]  A. Radunskaya,et al.  Mixed Immunotherapy and Chemotherapy of Tumors: Modeling, Applications and Biological Interpretations , 2022 .

[38]  M E Fisher,et al.  A mathematical model of cancer chemotherapy with an optimal selection of parameters. , 1990, Mathematical biosciences.

[39]  S. Sager,et al.  Optimal control for selected cancer chemotherapy ODE models: a view on the potential of optimal schedules and choice of objective function. , 2011, Mathematical biosciences.

[40]  R. Laubenbacher,et al.  Addressing current challenges in cancer immunotherapy with mathematical and computational modeling , 2017, bioRxiv.

[41]  K Renee Fister,et al.  Immunotherapy: an optimal control theory approach. , 2005, Mathematical biosciences and engineering : MBE.

[42]  Frank Nani,et al.  A chemotherapy model for the treatment of cancer with metastasis , 2002 .

[43]  John A. Adam,et al.  A mathematical model of cycle-specific chemotherapy , 1995 .